• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊液 - PR 2.0:神经退行性疾病定量脑脊液质谱数据交互式文献指南

CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.

作者信息

Guldbrandsen Astrid, Farag Yehia, Kroksveen Ann Cathrine, Oveland Eystein, Lereim Ragnhild R, Opsahl Jill A, Myhr Kjell-Morten, Berven Frode S, Barsnes Harald

机构信息

From the ‡Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, 5009 Bergen, Norway.

§KG Jebsen Centre for Multiple Sclerosis Research, Department of Clinical Medicine, University of Bergen, 5020 Bergen, Norway.

出版信息

Mol Cell Proteomics. 2017 Feb;16(2):300-309. doi: 10.1074/mcp.O116.064477. Epub 2016 Nov 27.

DOI:10.1074/mcp.O116.064477
PMID:27890865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5294216/
Abstract

The rapidly growing number of biomedical studies supported by mass spectrometry based quantitative proteomics data has made it increasingly difficult to obtain an overview of the current status of the research field. A better way of organizing the biomedical proteomics information from these studies and making it available to the research community is therefore called for. In the presented work, we have investigated scientific publications describing the analysis of the cerebrospinal fluid proteome in relation to multiple sclerosis, Parkinson's disease and Alzheimer's disease. Based on a detailed set of filtering criteria we extracted 85 data sets containing quantitative information for close to 2000 proteins. This information was made available in CSF-PR 2.0 (http://probe.uib.no/csf-pr-2.0), which includes novel approaches for filtering, visualizing and comparing quantitative proteomics information in an interactive and user-friendly environment. CSF-PR 2.0 will be an invaluable resource for anyone interested in quantitative proteomics on cerebrospinal fluid.

摘要

基于质谱的定量蛋白质组学数据支持的生物医学研究数量迅速增长,这使得全面了解该研究领域的现状变得越来越困难。因此,需要一种更好的方法来整理这些研究中的生物医学蛋白质组学信息,并将其提供给研究界。在本研究中,我们调查了描述与多发性硬化症、帕金森病和阿尔茨海默病相关的脑脊液蛋白质组分析的科学出版物。基于一套详细的筛选标准,我们提取了85个数据集,其中包含近2000种蛋白质的定量信息。这些信息可在CSF-PR 2.0(http://probe.uib.no/csf-pr-2.0)中获取,该平台包括在交互式且用户友好的环境中筛选、可视化和比较定量蛋白质组学信息的新方法。对于任何对脑脊液定量蛋白质组学感兴趣的人来说,CSF-PR 2.0将是一个宝贵的资源。

相似文献

1
CSF-PR 2.0: An Interactive Literature Guide to Quantitative Cerebrospinal Fluid Mass Spectrometry Data from Neurodegenerative Disorders.脑脊液 - PR 2.0:神经退行性疾病定量脑脊液质谱数据交互式文献指南
Mol Cell Proteomics. 2017 Feb;16(2):300-309. doi: 10.1074/mcp.O116.064477. Epub 2016 Nov 27.
2
Essential Features and Use Cases of the Cerebrospinal Fluid Proteome Resource (CSF-PR).脑脊液蛋白质组资源(CSF-PR)的基本特征及应用案例
Methods Mol Biol. 2019;2044:377-391. doi: 10.1007/978-1-4939-9706-0_25.
3
Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics.人类脑脊液蛋白质组学:使用定量蛋白质组学发现和验证神经退行性疾病的生物标志物候选物。
J Proteomics. 2011 Apr 1;74(4):371-88. doi: 10.1016/j.jprot.2010.11.010. Epub 2010 Nov 25.
4
Advancing cerebrospinal fluid biomarker discovery by mass spectrometry.通过质谱法推进脑脊液生物标志物的发现
Neurodegener Dis Manag. 2015 Oct;5(5):371-3. doi: 10.2217/nmt.15.35. Epub 2015 Oct 19.
5
Proteomics of brain extracellular fluid (ECF) and cerebrospinal fluid (CSF).脑细胞外液(ECF)和脑脊液(CSF)的蛋白质组学。
Mass Spectrom Rev. 2010 Jan-Feb;29(1):17-28. doi: 10.1002/mas.20213.
6
Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset.脑脊液细胞外囊泡的蛋白质组学分析:一个综合数据集。
J Proteomics. 2014 Jun 25;106:191-204. doi: 10.1016/j.jprot.2014.04.028. Epub 2014 Apr 24.
7
Preparation of human cerebrospinal fluid for proteomics biomarker analysis.用于蛋白质组学生物标志物分析的人脑脊液制备
Methods Mol Biol. 2013;1002:61-70. doi: 10.1007/978-1-62703-360-2_5.
8
Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.无标记定量嗅觉蛋白质组学在检测突触核蛋白病脑脊液生物标志物候选物中的应用
Methods Mol Biol. 2019;2044:273-289. doi: 10.1007/978-1-4939-9706-0_17.
9
Characterization of individual mouse cerebrospinal fluid proteomes.个体小鼠脑脊液蛋白质组的表征
Proteomics. 2014 May;14(9):1102-6. doi: 10.1002/pmic.201300241. Epub 2014 Mar 20.
10
Mass spectrometry-based proteomics of cerebrospinal fluid in pediatric central nervous system malignancies: a systematic review with meta-analysis of individual patient data.基于质谱的小儿中枢神经系统恶性肿瘤脑脊液蛋白质组学:一项基于个体患者数据的系统评价和荟萃分析。
Fluids Barriers CNS. 2024 Feb 13;21(1):14. doi: 10.1186/s12987-024-00515-x.

引用本文的文献

1
Discovery and validation of biomarkers for Parkinson's disease from human cerebrospinal fluid using mass spectrometry-based proteomics analysis.使用基于质谱的蛋白质组学分析从人脑脊液中发现和验证帕金森病的生物标志物
EBioMedicine. 2025 Aug;118:105844. doi: 10.1016/j.ebiom.2025.105844. Epub 2025 Aug 5.
2
Targeted Absolute Quantification of Protein Biomarkers in Cerebrospinal Fluid by FastCAT.通过FastCAT对脑脊液中的蛋白质生物标志物进行靶向绝对定量分析。
Methods Mol Biol. 2025;2914:65-74. doi: 10.1007/978-1-0716-4462-1_6.
3
Central nervous system-derived extracellular vesicles: the next generation of neural circulating biomarkers?中枢神经系统来源的细胞外囊泡:新一代神经循环生物标志物?
Transl Neurodegener. 2024 Jun 19;13(1):32. doi: 10.1186/s40035-024-00418-9.
4
Natalizumab promotes anti-inflammatory and repair effects in multiple sclerosis.那他珠单抗促进多发性硬化症的抗炎和修复作用。
PLoS One. 2024 Mar 25;19(3):e0300914. doi: 10.1371/journal.pone.0300914. eCollection 2024.
5
Comparative analysis of hippocampal extracellular space uncovers widely altered peptidome upon epileptic seizure in urethane-anaesthetized rats.比较分析海马细胞外空间揭示了在乌拉坦麻醉大鼠癫痫发作时广泛改变的肽组。
Fluids Barriers CNS. 2024 Jan 11;21(1):6. doi: 10.1186/s12987-024-00508-w.
6
A beginner's guide into curated analyses of open access datasets for biomarker discovery in neurodegeneration.生物标志物发现的开放获取数据集策展分析入门指南。
Sci Data. 2023 Jul 6;10(1):432. doi: 10.1038/s41597-023-02338-1.
7
Multi-Omics Interdisciplinary Research Integration to Accelerate Dementia Biomarker Development (MIRIADE).多组学跨学科研究整合以加速痴呆生物标志物开发(MIRIADE)。
Front Neurol. 2022 Jul 12;13:890638. doi: 10.3389/fneur.2022.890638. eCollection 2022.
8
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation.阿尔茨海默病中磷脂酰乙醇胺结合蛋白 1(PEBP1):ELISA 开发与临床验证。
J Alzheimers Dis. 2022;88(4):1459-1468. doi: 10.3233/JAD-220323.
9
Signatures of glial activity can be detected in the CSF proteome.脑脊液蛋白质组中可检测到神经胶质细胞活性的特征。
Proc Natl Acad Sci U S A. 2022 Jun 14;119(24):e2119804119. doi: 10.1073/pnas.2119804119. Epub 2022 Jun 6.
10
Proteomic Approaches to Study Cysteine Oxidation: Applications in Neurodegenerative Diseases.用于研究半胱氨酸氧化的蛋白质组学方法:在神经退行性疾病中的应用
Front Mol Neurosci. 2021 Jun 9;14:678837. doi: 10.3389/fnmol.2021.678837. eCollection 2021.

本文引用的文献

1
Change..
J Proteome Res. 2016 Aug 5;15(8):2355. doi: 10.1021/acs.jproteome.6b00640. Epub 2016 Jul 22.
2
Identification of brain-enriched proteins in the cerebrospinal fluid proteome by LC-MS/MS profiling and mining of the Human Protein Atlas.通过液相色谱-串联质谱分析和挖掘人类蛋白质图谱来鉴定脑脊液蛋白质组中脑富集蛋白。
Clin Proteomics. 2016 May 15;13:11. doi: 10.1186/s12014-016-9111-3. eCollection 2016.
3
Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition.骨桥蛋白——上皮-间质转化的主要调节因子
J Clin Med. 2016 Mar 23;5(4):39. doi: 10.3390/jcm5040039.
4
Label-free analysis of human cerebrospinal fluid addressing various normalization strategies and revealing protein groups affected by multiple sclerosis.针对多种归一化策略的人脑脊液无标记分析,揭示受多发性硬化症影响的蛋白质组。
Proteomics. 2016 Apr;16(7):1154-65. doi: 10.1002/pmic.201500284.
5
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.用于神经退行性变的新型脑脊液生物标志物的鉴定及其通过高通量多重靶向蛋白质组学分析的验证。
Mol Neurodegener. 2015 Dec 1;10:64. doi: 10.1186/s13024-015-0059-y.
6
Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis.基于蛋白质的分类器预测临床孤立综合征向多发性硬化症的转化
Mol Cell Proteomics. 2016 Jan;15(1):318-28. doi: 10.1074/mcp.M115.053256. Epub 2015 Nov 9.
7
Exploring the potential of public proteomics data.探索公共蛋白质组学数据的潜力。
Proteomics. 2016 Jan;16(2):214-25. doi: 10.1002/pmic.201500295. Epub 2015 Dec 15.
8
Osteopontin in Immune-mediated Diseases.免疫介导疾病中的骨桥蛋白
J Dent Res. 2015 Dec;94(12):1638-45. doi: 10.1177/0022034515605270. Epub 2015 Sep 4.
9
Quantitative proteomics suggests decrease in the secretogranin-1 cerebrospinal fluid levels during the disease course of multiple sclerosis.定量蛋白质组学研究表明,在多发性硬化症的病程中,分泌粒蛋白-1的脑脊液水平会降低。
Proteomics. 2015 Oct;15(19):3361-9. doi: 10.1002/pmic.201400142. Epub 2015 Sep 8.
10
Integrative biomarker discovery in neurodegenerative diseases.
Wiley Interdiscip Rev Syst Biol Med. 2015 Nov-Dec;7(6):357-79. doi: 10.1002/wsbm.1310. Epub 2015 Jul 2.